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Abstract 
The nematode is a microscopic* worm belonging to the phylum Nematoda. With over 2200 
described genera in about 250 families, the nematode is among the most diverse of all 
pseudocelomates. These worms are the most ubiquitous multicellular organisms on earth and are 
crucial for maintaining soil nutrients and overall symbiotic relationships between plants and certain 
organisms.1-3 However, as many as 33% of the estimated 40,000 nematode species have been 
classified as parasitic.4 Of particular interest to the farming community, nematode parasites can 
infect plants (e.g. corn, soybean and wheat), animals (e.g. pigs, sheep, goats and cows) and even 
humans, causing illness and severe agricultural loss.1-3 Conventional control methods based on 
chemotherapy face a major challenge as nematodes are developing resistances to the known 
nematocides.1 As new resistant isolates emerge and new drugs are developed to control them, there 
is a great need for improved methods of screening resistance and determining dose response.  
 
In this thesis, a microfluidic platform for screening drugs and their dose response on the locomotive 
behavior of parasitic nematodes is presented. The system offers reduced experimental time, higher 
sensitivity, and, for the first time, real-time observation of drug effects at a single worm resolution. 
The presented lab-on-chip bioassay can be reliably used to identify changes in multiple locomotion 
parameters and to determine exposure effects as a function of time. Existing nematode motility and 
migration assays do not offer such a level of sophistication.  
 
The device comprises two principal components: (i) microchannels to study nematode motility 
during the pre- and post-exposure periods of the experiment and (ii) a drug well for administering 
the dose and studying drug effects at different exposure times. The drug screening experiment can 
be described by three main phases: (i) ‘pre-exposure study’ - worms are inserted into the 
microchannels and their locomotion is characterized, (ii) ‘dose exposure’ – worms are guided from 
the microchannels into the drug well and exposed to a dose for a predefined time and (iii) ‘post-
exposure study’ – worms are guided back into the microchannels where their locomotion is 
characterized and compared to pre-exposure motility.  
 
                                                          
*
 The nematode is typically microscopic, but can range from micrometers to millimeters in size. The worms studied in this thesis were 
~400µm in length when stretched (i.e. not in a sinusoidal position) and measured from head to tail.  
ix 
 
We demonstrate the workability of the microfluidic platform on the parasitic Oesophagotomum 
dentatum (levamisole sensitive, SENS and levamisole resistant, LEVR) using levamisole as the test 
drug. The proposed scheme of drug screening on a microfluidic device is expected to significantly 
improve the resolution, sensitivity and throughput of in vivo nematode testing, while offering new 
details on the real-time exposure effects of new and existing anthelmintics.            
 
A second project, ‘the electrotactic nematode gate’, is presented as a byproduct of the 
aforementioned lab-on-chip bioassay. Current microfluidic methods for gating (i.e. opening or 
closing a certain pathway to) nematode movement use a pinch type or polymer membrane valve.5-7 
Although effective, these valves are generally large static structures, lack the potential for 
automation and, in some cases, require a multistep molding process. The electrical gate presented 
in this thesis advantageously uses the electrotactic response of nematodes to generate a dynamic, 
microscale gate that can be easily programmed and integrated into an automated bioassay. The 
gate requires only two electrode ports that have a separation larger than the nematodes’ 
penetration depth (10-300 µm depending on species) and can therefore be fabricated as a single-
mold microfluidic device. It is expected that the presented device will help to streamline new and 
existing bioassays, especially in the Caenorhabditis elegans community.   
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Chapter I: Introduction 
Electrical Engineering – Biomedical Sciences Collaboration 
The electrical engineering-biomedical sciences collaboration at Iowa State University [in the opinion 
of the author] was created with two main mission statements: (i) to advance the community’s 
knowledge of nematode biology and (ii) to design microfluidic chips and methods that enable other 
research groups to better study nematode biology. The collaboration can be categorized in the 
realm of bioengineering and has the unique advantage of offering the engineer’s input to biology 
and the biologist’s input to engineering.  
The Research Path  
Figure 1 depicts a block diagram of the research path followed during this Master’s study. Each block 
in this diagram will be expanded and described in detail throughout this thesis.   
 
Figure 1: Block diagram of research path 
 
The research spawns from an increase in drug resistance found in parasitic nematodes. In the first 
phase of research, altered phenotype associated with this resistance was studied. Next, 
advantageously using the results from phase one, a real-time dose response assay was proposed 
and design parameters to be developed were defined. These parameters, which centered on the 
electrotactic response of the nematodes, were then studied in phase three; which concluded with a 
Altered Phenotype
Real-Time Dose Assay
Parasitic Drug Resistance
ElectrotaxisLevamisoleTribendimidine
Sensitivity Ω channel τ response
E-Gate
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working prototype of the real-time dose assay. In the final phase, the effects of the pilot-drug 
Levamisole were studied using the new assay and the results were compared to published data. It 
should also be noted that the dose assay was used to collect initial data on a new drug – 
tribendimidine. This data was correlated with data from an established assay and a more complete 
study using the new assay is ongoing. A final project, the E-Gate, spawned as an offshoot to the 
electrotaxis study. Although this project is unrelated to the dose assay, it is a byproduct of the 
research used to develop the bioassay and is expected to make an impact in the C. elegans 
community.  
Background: Microfluidics and Nematodes 
The nematode, typically microscopic in size (Figure 2), is a roundworm belonging to the phylum 
Nematoda. Divided into >2200 genera and ~256 families, as many as 13,200 of the 40,000† known 
nematode species have been classified as parasitic (e.g. Oesophagotomum dentatum (O. 
dentatum)).4 These infectious parasites can be detrimental to plant (e.g. corn and soybean) and 
livestock (e.g. pig and cow) life, causing severe agricultural loss. Thus, the study of parasitic 
nematology has gained prevalence in today’s research community.   
 
 
Figure 2: C. elegans N2 nematode 
 
Further, of particular interest to biology community, the nematode species Caenorhabditis elegans 
(C. elegans) has become a model organism as it was the first multi-cellular organism to have its 
genome completely sequenced. A model organism can be defined a non-human species that is 
                                                          
† It has been estimated that about 16,000-17,000 species have been described and that at least 40,000 species exist. Other estimates of 
500,000 to 1,000,000 species have been reported, but I will present the most conservative estimate with the pretext of ‘at least’. 
Reproduction System
Excretory System Digestive System
Nerve Ring
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extensively studied to understand particular biological phenomena8, thus, emphasis on the 
development of lab-on-chip techniques to study C. elegans has recently grown.  
 
Microfluidics can be defined as the study of transport processes in microchannels.9 It is the science 
of systems that process or manipulate small amounts of fluid.10 In the case of this research, the 
transport process is not fluidic per say, but locomotive (i.e. the nematodes’ movement). Perhaps a 
more ideal definition [as it pertains to this research] would be bioMicrofluidics: the use of micro-
scaled, fluid filled channels to study nano- or microscopic biology. The concept of microfluidics dates 
back the 1980s where the desire to miniaturize networks of plastic tubing and connectors set the 
foundation for microchannels. Phrases such as ‘small-volume flow cells’, ‘miniaturized total chemical 
analysis’ and ‘capillary electrophoresis’ became prominent in the early 1990s and by 2003, 
microfluidics had grown into a 3.5 billion dollar industry.  A commonly asked question is “why is 
electrical engineering coupled with microfluidics”, as there is typically little or no electricity 
associated with these fluidic devices. To answer this question we look to the earliest microfluidics 
work where devices were fabricated by microelectronic methods on silicon and glass substrates. We 
can see some of the pioneers of the field were electrical engineers – experts in microelectronic and 
microeletromechanical (MEM) fabrication. Thus, microfluidics has traditional been categorized as a 
microanalytical system in the realm of electrical engineering.    
 
Present day microfluidic devices typically consist of microchannels, I/O ports, valves, a fluidic 
medium, etc. and is fabricated using a standard soft lithography (SL) process. This process flow can 
be broken into two main phases: (i) ‘Master Mold Fabrication’ and (ii) ‘Polymer Molding’. The 
following summarizes the SL process:  
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Figure 3: Soft lithography summary 
 
Master Mold : Photoresist spin, prebake  Photolithography pattern  Photoresist 
develop  hardbake 
 
Polymer Mold: Pre-polymer pour, vacuum dissection  polymer cure (hardbake)  
polymer peel, trim  plasma bond 
 
As a simplistic overview, a silicon wafer is patterned with photoresist to create a ‘master mold’. A 
pre-polymer mixture is them poured onto the mold and allowed to cure. The hardened polymer is 
pealed from the mold bonded to a glass slide, creating a microfluidic device.  
 
Due to the micro-scale of these fluidic devices, microfluidics allows increased experimental accuracy 
(i.e. lower volume and higher control), improved observational power (i.e. integration with an 
imaging system and the potential for automation), and lowered analysis cost (i.e. the devices are 
cheap and disposable). Hence, these chips offer numerous advantages for the advancement of 
nematology.   
Photoresist 
spin 
Pattern 
PDMS 
pour 
PDMS Cure Peal, Trim 
Punch, Bond 
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Chapter II: Characterizing Altered Phenotype 
In this chapter an introduction to the study of in vivo nematode locomotion with microfludic devices 
is described. This chapter represents phase I of this research and, although not the main topic of 
this thesis, is presented as initial methods and results for chapter III.  
Background: An Introduction to Resistance 
Of the known nematode species, it is thought that up to 33% are parasitic.4 Of particular interest to 
the farming community, nematode parasites can infect both plants and livestock, causing massive 
economic loss. Further, in humans, the parasites can depress growth and cognitive development in 
children, as well as, contribute to illness in adults. Control of these infections rely on regular 
chemotherapy but, inevitably, drug resistance has become a major concern in animal infecting 
nematodes1 and is emerging in human infecting nematodes2. Early detection of drug resistance is 
necessary for limiting its spread. Although some molecular methods are available for detecting a 
changed genotype associated with resistance3, 11, detection of resistance in nematode parasites is 
mainly based on detecting a changed phenotype as many classes of anthelmintics (haloxon, 
levamisole, monepantel, derquantel, ivermectin and piperazine) act on the neuromuscular system 
of nematodes to inhibit locomotion12-13.  
 
 
Figure 4: Images of sinusoidal nematode motion 
 
A majority of nematodes rely on a side-to-side sinusoidal movement to ‘swim’ over solid surfaces 
(Figure 4). Their mechanism of locomotion has intrigued researchers for several decades and 
inspired a number of quantitative models to describe its nature.14-17 In the model nematode, C. 
elegans, locomotion experiments have often been performed on agar plates to show the C. elegans 
use the surface tension of thin water film and its internal hydrostatic pressure to generate a forward 
motion force.18-20 In this movement, an oscillatory movement of the head is propagated backwards 
along the rest of the body as sinusoidal waves.16, 21  
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In this section, we extend the application of microfluidics technology to the study of this sinusoidal 
movement and demonstrate phenotypic variations in nematode locomotion associated with 
resistance. Most importantly, the approach can distinguish between different isolates of the same 
species. We designed and fabricated microfluidic bioassays to record and characterize the 
undulatory movement of larvae of the pig parasite Oesophagostomum dentatum, as well as two 
isolates of O. dentatum: levamisole-sensitive (SENS), which are sensitive to the cholinergic 
anthelmintic levamisole and levamisole-resistant (LEVR) which are resistant to the drug.13 The 
locomotion parameters under study were the velocity of forward migration, amplitude and 
wavelength of the sinusoidal motion, and the frequency of the side-to-side swimming action. We 
observed clear differences between SENS and LEVR O. dentatum larvae allowing the drug resistant 
phenotype to be recognized in the absence of the anthelmintic. Further, we characterized the 
anthelmintic dose response for SENS and LEVR isolates and noticed differences in the degree of 
motility parameter degradation, which is indicative of a link between resistance and phenotype of 
locomotion. 
Experimental 
As previously noted, nematodes rely on a segmented tangential force to produce forward 
movement. This force generates an oscillatory movement that manifests through the body as a 
sinusoidal wave. Equation 1 shows a quantitative description of this tangential force. 
 
 
Equation 1: Tangential Force 
Where Fo is a normalization factor to account for body mass, surface tension, frictional force, and a 
couple moment, A is the amplitude of the sinusoidal nematode, and   is the wavelength of the 
nematode (Figure 5).  
 
Figure 5: Wavelength, amplitude and velocity direction of typical nematode 
 2/21
/2


A
A
F
F
O
T


10m
Amplitude
Wavelength
Velocity
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As shown in Equation 1 the tangential force, and, hence, forward velocity, relies heavily on the 
amplitude and wavelength of the sinusoidal nematode. Thus, by quantifying the nematodes’ 
amplitude, wavelength, forward velocity, and tangential force, it is possible to differentiate between 
nematode species and isolates.  
 
To study the locomotion parameters, microfluidic devices were designed to have four straight, 
parallel channels (width = 300 µm, length = 1 cm, height = 40 µm), each with individual input and 
output ports. After fabrication of the device using a standard soft lithography technique22-24, 0.8% 
(w/v) agar (Fischer Scientific) in water was prepared and magnetically stirred at 90ºC until fully 
dissolved. A syringe, fitted with a small tube and polydimethylsiloxane (PDMS) plunger, was used to 
fill each channel with agar through the I/O ports. The agar was then allowed to cool into a gel and a 
few milliliters of a nematode dilution (2 worms/µl) was placed onto each of the four input ports. 
After a small ‘scouting time’ (5 to 10 minutes), the nematodes began to move through the agar gel 
and populated the channels.  
 
In order to observe and record the nematodes’ motility, a Leica MZ16 transmission 
stereomicroscope was used. The microscope had both a 1x and 2x objective lens, enabling 7.1x to 
230x magnification which was adequate for the designed experiments.25-26 The microscope was 
coupled with a QICAM 12-bit Mono Fast 1394 cooled digital camera interfacing with QCapture PRO 
software, allowing the capture of digital images (1392 × 1040 pixels) at a specified time interval 
(typically one second). The images were then sequenced together and compressed into an .avi video 
format. Each video was then manually post processed and the morphological parameters were 
quantified.    
Results and Discussions 
Amplitude 
As depicted in Figure 5, the amplitude is defined as the bottom most point of the worm’s sinusoidal 
position to the top. Although amplitude for a single worm may vary slightly throughout the course of 
forward movement, a representative quantification was found by averaging numerous 
measurements together. We observed differences in the amplitude between nematode isolates and 
species. SENS had an average amplitude of 135.2 ± 1.7 µm (n = 32) which was significantly (p < 
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0.001) larger than LEVR (122.5 ± 1.8 µm; n = 35). In the presence of 1 µM levamisole, there was a 
significant reduction in the amplitude of SENS (reduced to 121.3 ± 1.9 µm, n = 38, p < 0.001) but not 
in LEVR (124.8 ± 1.9 µm, n= 27, p = 0.39). This shows that the resistance isolate (LEVR) can be 
identified in the absence of the anthelmintic by monitoring the worms’ amplitude. Further, we see 
that in the presence of relatively low dose of levamisole, the amplitude of SENS’s forward 
movement degrades much more quickly than LEVR’s (SENS≈10% reduction; LEVR≈0%).  This is an 
encouraging observation as it is indicative of LEVR’s resistance and a changed phenotype.  
 
A second cross species comparison was performed between O. dentatum and H. glycines. The mean 
amplitude value (89.6 ± 1.8 µm; n = 150) for H. glycines, was found to be significantly smaller than 
the SENS and LEVR isolates of O. dentatum (p < 0.001). This shows that it is possible to distinguish 
between two species by characterizing their sinusoidal amplitude. 
Wavelength 
The wavelength is defined as the distance between two adjacent minimums [or peaks] of the 
worms’ sinusoidal position. Again, a statistically significant difference between the wavelengths of 
SENS and LEVR isolates (p = 0.019) was found. SENS had a mean wavelength of 372.9 µm ± 7.1 µm (n 
= 32) whereas LEVR had a mean wavelength of 393.1 ± 4.6 µm (n = 35). 1 µM levamisole did not 
have a statistically significant effect on the wavelengths of either isolates.  This shows that, in 
conjunction with sinusoidal amplitude, wavelength can also be monitored to distinguish between 
the isolates of O. dentatum in the absence of anthelmintics. 
 
In the second cross-species comparison, the mean wavelengths of H. glycines was 310.2 ± 3.3 µm 
(mean, ± s. e., n = 150) was found to be significantly smaller than the wavelength of SENS isolate (p < 
0.001). 
A/ λ quotient 
The data gathered for our amplitude and wavelength analysis were used to obtain a set of A/λ 
quotients. The mean of A/λ quotients for the SENS isolate was 0.366 ± 0.007 (n = 32), while that for 
the LEVR isolate was 0.313 ± 0.005 (n = 35) which was significantly smaller (p < 0.0001). After 
exposure to 1 µM levamisole, the mean A/λ quotient of SENS isolate showed a 13% decrease to 
0.317 ± 0.005 (n = 38, p < 0.001) whereas the LEVR isolate showed a 4.6% increase to 0.327 ± 0.006 
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(n = 27, p > 0.05). The A/λ quotient of H. glycines was 0.289 ± 0.008 (n = 150). The cross-species 
comparison between the A/λ quotients again revealed a significant (p < 0.001) difference. 
Tangential force 
The above mentioned A/λ quotient values allowed us to indirectly calculate the tangential force 
exerted by the nematode for its forward motion. A classical work derived the maximum forward 
tangential force, FT, exerted by a half-wave of the nematode body and related it to its body 
parameters.14-15, 17 This equation is presented in Equation 1 where the normalization factor Fo is 
dependent on parameters such as body mass, surface tension, frictional force, and coupling 
moment which are assumed relatively unchanged in our experiments.14 As illustrated in Figure 5, the 
body of a nematode can be viewed as different segments where each individual segment applied a 
tangential force FT for the forward propulsive motion. We observed that this tangential force 
increases with increase in amplitude and decrease in wavelength, which makes intuitive sense from 
the aforementioned quantitative model.  
 
Using Equation 1, the mean of the normalized tangential force for the SENS isolate was found to be 
2.49 ± 0.05 × 10-3 (n = 32) while that for the LEVR isolate was significantly smaller (p < 0.001), 2.27 ± 
0.03 × 10-3 (n = 35).  When considering the earlier presented data, this result is expected. As 
previously stated, we found a significant difference between the SENS and LEVR amplitude. Because 
of the increase in the SENS amplitude it is expected that an increase should also manifest in the 
normalized tangential force.  After exposure to 1 µM levamisole, the mean normalized force of the 
SENS isolate showed a 6.0% decrease to 2.34 ± 0.04 × 10-3 (n = 38, p < 0.02) whereas the LEVR 
isolate showed no significant change with a value of 2.36 ± 0.04 × 10-3 (n = 27, p > 0.05).  
 
In the cross-species comparison, the mean of the normalized tangential force for H. glycines was 
found to be 2.84 ± 0.03 × 10-3 (n = 150) which was 13.7% greater than that of the SENS isolate. 
Further discussions 
The above results show our ability to study nematode locomotion parameters using a microfluidic 
platform. Further, we reported phenotypic variations in these parameters in both the absence and 
presence of levamisole. These results are important to this thesis as they paved the way for the 
microfluidic platform presented in chapter III and show that by monitoring motility, a dose 
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response can be generated and level of resistance can be determined. It is noted that in this section 
results for amplitude, wavelength and normalized force were presented, but in the subsequent 
chapter, velocity will be monitored as it is representative of the abovementioned motility 
parameters (i.e. the speed of forward movement depends on the tangential force generated, which 
is dependent on wavelength and amplitude). 
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Chapter III: Real-Time, High-Sensitivity (RTHS) Dose Assay 
Having studied nematode locomotion and the changes associated with drug resistance, the scope of 
this thesis then switched to developing a microfluidic bioassay to screen resistance and generate a 
multi-parameter dose response. The results from chapter II are advantageously used and built upon 
during the development of this bioassay. Our research, results, and conclusions are presented in the 
subsequent chapter.  
Background: Current Assays and Highlighted Issues 
Present-day nematode motility assays (e.g. larval migration assay27) are based on a mesh system in 
which the worms resistant to a certain anthelmintic are able to move through the mesh, whereas 
the sensitive worms are restricted. A simple worm count gives the percentage of worms that were 
inhibited by the drug under test. Even though these assays are simple to use and give a fairly good 
representation of survivability, they lack the throughput and information content needed to 
adequately test one or a range of anthelmintic compounds.27 Specifically, there are four main 
drawbacks to these motility assays. First, measurements are conducted on a worm population (50-
100 samples) as it is difficult to evaluate a single nematode. Second, only one output parameter is 
monitored (e.g. percentage survivability or inhibition). Third, real-time observation of drug effect is 
not possible. Fourth, the total time for one experiment is at least 4-6 hours for even a trained 
experimentalist.13, 28 These drawbacks limit the design scope and flexibility of present day motility 
assays. As an alternative to motility assays, electrophysiological experiments conducted on the non-
parasitic model nematode, Caenorhabditis elegans,29-30 with specific ion-channels as drug targets 
provide valuable information about drug interactions at the molecular and cellular level but are 
labor-intensive and with low throughput.13    
 
Recent advances in microfluidics have led to a new class of devices (culture and detection 
chambers,23, 31-32 cylindrical posts,17 mazes,33  piezoresistive sensors,34 microtraps,5-6 optofluidic 
microscopes,35 clamp arrays36 and olfactory chips37) to study the neurophysiology and behavior of C. 
elegans and other nematode species. Microfluidics technology provides the potential advantage of 
conducting numerous experiments in parallel on the same chip with less reagents, improved 
sensitivity, and increased resolution.23, 31 This, along with much improved imaging systems and 
automated data processing, have enabled the observation and characterization of key behavioral 
parameters in vivo at a micro- and nanoscale resolution. This has also inspired researchers to 
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develop better quantitative models to describe phenotypic differences in nematodes under realistic 
environmental conditions.16, 38-40 As presented in chapter I, in a related work on the application of 
microfluidics to parasitology, we fabricated microchannels and showed that the average velocity, 
oscillation frequency, and body parameters (i.e. amplitude and wavelength) can be significantly 
different for levamisole-sensitive and levamisole resistant strains of a nematode species (O. 
dentatum).41 This work, coupled with the recent advances in microfluidics, has enabled us to 
develop a drug screening assay capable of addressing the aforementioned drawbacks of current 
motility assays.   
RTHS Dose Assay Proposal 
Here we present a new microfluidic platform for screening drug resistance of C. elegans and 
parasitic nematodes. Compared to the above mentioned nematode motility assays, our platform 
offers key advantages which help on improving the throughput and information content of drug 
screening experiments. For the first time, a microfluidic device is fabricated to observe the effect of 
anthelmintics on the locomotion behavior of nematodes at real-time.  
 
Figure 6: 3-D model of proposed dose assay 
 
The device, depicted in Figure 6, consists of two microchannels (width = 300 µm, length = 1 cm, 
height = 80 µm), a drug well, input/output (I/O) port, drug port and electrode port. The proposed 
experiment was run in three consecutive phases (Figure 7): (i) ‘pre-exposure study’, (ii) ‘dose 
exposure’ and (iii) ‘post-exposure study’.  
I/O port
Electrode port
Drug port
Drug well
Glass Slide
Microchannels
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Figure 7: Three-phase RTHS assay experiment 
 
The worms were first inserted into the microchannels through the I/O port and pre-exposure 
locomotion (e.g. average forward velocity) was characterized. The worms were then guided through 
the microchannels into the drug well, where they were held for a predefined exposure time. During 
this period, the effects of the drug on locomotion were monitored and characterized at real time. 
Lastly, the worms were guided back into the microchannels and post-exposure locomotion was 
characterized and compared to pre-exposure locomotion. Electrotaxis has been employed here as a 
reliable means to guide the movement of nematodes into and out of the drug well. Video recording 
of the entire experiment, along with an automated worm tracking software, reveals important 
information about changes in the worms’ locomotion during the entry, drug exposure, and exit 
periods. This information helps us develop dose response characteristics of drug resistance. 
Furthermore, previously reported worm tracking programs were designed for studying C. elegans 
locomotion on agarose plates or sorting immobilized C. elegans mutants in microchannels based on 
phenotypic observations.25, 42-44 Our tracking software has the added advantage of autonomously 
measuring subtle locomotion changes in both C. elegans and other nematode species in microfluidic 
devices in the presence or absence of drugs. Such real-time observation of drug effects on a single 
worm has not been possible before. Because of the microfluidic design, we are able to record and 
measure a number of locomotion parameters beyond the single parameter (i.e. survivability) 
observed in motility assays which improves the experimental sensitivity. We also reduced the 
experimental time for a single run (from 4-6 hours13, 28 to 45-60 minutes) and have shown significant 
improvement in throughput by running multiple (at least 4) experiments in parallel on a single chip 
(Figure 8).         
(I) (II) (III)
5 V/cm 5 V/cm5 V/cm
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Figure 8: RTHS Dose assay chip layout 
 
In order to realize a reliable drug screening platform independent of nematode species and test 
drug, several experimental aspects needed to be investigated. First, the electrotactic response of 
the nematode was characterized in the ‘electrotaxis preference experiment’. Second, the nematode 
behavior in different conditions of electric field and current were studied in the ‘electrotaxis 
sensitivity experiment’. Next, a method for selectively filling the miro-device in order to maintain 
chemical separation without sacrificing electrical continuity was developed. Lastly, the dose 
response and real-time exposure effects of the anthelmintic drug levamisole on the parasitic O. 
dentatum (levamisole sensitive, SENS and levamisole resistant, LEVR) was studied in the ‘real-time 
screening experiment’. The details of the experimental setups and results are presented next.  
Electrotaxis 
A key element towards developing the microfluidic drug screening platform was the use of electrical 
field to direct the worms from the microchannel into a drug well, hold them in there for a 
predefined time duration (e.g. ~20 minutes), and then guide them back through the microchannel. 
Electrotaxis of C. elegans has been shown on agarose plates and in microscale chambers where the 
worms move towards the cathode.45-47 Switching the direction of the electric field switched the 
direction of the C. elegans’ movement. Two theories as to why this phenomenon is observed are 
offered in the current literature: (i) neuromuscular contraction caused by the charge transfer 
electrons and (ii) direct sensing of ion gradients within the platform. The first was dismissed by 
Sukul45, however, we will see later in the channel resistance section that neuromuscular contraction 
cannot be ignored at high currents. The second was proposed as a high probability explanation as 
previous experiments show that C. elegans move towards or are repelled by ion gradients generated 
by sodium (Na+), potassium (K+), chloride (Cl-) and hydroxyl (OH-), however work directly confirming 
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this theory could be found. The aforementioned ion gradient work can be directly applied to our 
assays [as the channels are filled with 99.2% tap water] to give some insight as to why electrotaxis is 
viable in our platform. 
 
 
Equation 2: Chloride ion formation and the electrolysis of water 
 
Equation 2 shows the chloride ion formation and the electrolysis of water. As will be shown in 
subsequent sections an applied field >2V/cm is used to induced the nematode electrotactic 
response, hence, it is suspected there is an appreciable amount of the chloride ion gathering nearing 
the anode and a appreciable hydroxyl  ion gradient within the channel.  It has been previously 
reported that an accumulation of chloride repels the C. elegans nematode while the hydroxyl ion 
attracts the worms. 45 Thus, nematode movement   away from the anode and towards the cathode 
is expected.  
Polarity Choice: Experimental and Results 
The published work on electrotactically-guided nematode movement was demonstrated only on a 
few C. elegans mutants and left open questions as to its applicability to other nematode species and 
in combination with drug exposure. We speculated that the electrotaxis technique could be reliably 
used on other nematode species to guide them in and out of the drug well in a controlled fashion. 
 
 
Figure 9: Polarity choice chip layout 
 
0V [anode] 
-4V [cathode #2] 
-10V [cathode #1] 
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To demonstrate electrotaxis on the drug relevant nematodes species studied here, we needed to 
characterize the preference of a given nematode species to range of different electric fields. To test 
electric field preference, T-shaped microfluidic devices were fabricated (width = 300 µm, length = 1 
cm, height = 80 µm) (Figure 9). The devices consist of three I/O ports connected via straight 
microchannels. The nematodes were placed in the left port and voltages were applied through the 
electrodes to establish two uniform electric fields. The anode (left port) was biased at 0V and the 
cathodes (right ports) were biased at two different negative voltages. The worms were free to move 
about the microchannels, their progression was recorded, and a data set containing number of 
worms collected at each cathode was obtained.  
 
 
Figure 10: Polarity choice results 
 
Figure 10 plots the preference of SENS and LEVR O. dentatum nematodes when choosing between a 
pair of electric field strengths in the T-shaped microchannels (Fig. 2a). The data presented in the 
four bar graphs (Fig. 2b i-iv) shows that a high percentage (>80%) of the O. dentatum isolates prefer 
to travel towards the cathode having the lower potential. For example, in Figure 10ii, more than 
89% (n=49, SENS and n=68, LEVR) of O. dentatum isolates chose to travel to the cathode kept at an 
electric field of 4V/cm while less than 10.5% of the nematodes move to the cathode kept at 2V/cm. 
Furthermore, Figure 10i demonstrates that, when given an option between a floating cathode 
(which has no electric field) and a cathode kept at a finite electric field (4V/cm), the worms choose 
the path of nonzero electric field. This shows that nematodes prefer to move in the path of the field 
lines rather than seeking an escape route out of the area of field application. As seen from all the 
graphs, there is no significant difference between SENS and LEVR isolates in their direction of 
preference. We conducted similar tests on C. elegans and observed that they also prefer to move 
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towards the more negative cathode. Hence, the application of electric field could be used as a 
reliable means of guiding nematodes into and out of different sections of a microfluidic device. 
Sensitivity: Experimental and Results 
We next investigated the ideal range of electric field for guiding the nematodes throughout the 
microfluidic device without adversely damaging their natural sinusoidal movement. This range of 
electric field was investigated in two steps. First, by sweeping the cathode voltage at a high (>10 
MΩ) microchannel resistance, a minimum electric field was found at which the direction of the 
nematodes movement could be reliably controlled. Second, by varying the microchannel resistance 
at a fixed cathode voltage (~4.5V), a maximum allowable current was found beyond which the 
nematodes paralyze. This value of current was used to infer the maximum allowable electric field for 
a given microchannel resistance. 
 
Figure 11: Electrotaxis sensitivity chip layout 
 
The test for electrotaxis sensitivity was performed on straight microchannels (width = 300 µm, 
length = 1 cm, height = 80 µm) (Figure 11). Similar to the procedure in the above mentioned T-
shaped devices, the nematodes were placed into the I/O port and a uniform electrical field was 
established. To find the minimum electric field, the anode was kept at 0V while the cathode was 
biased at certain negative voltage (-1.0V to -5.0V). The anode and cathode were interchanged once 
every minute, hence, switching the direction of the electric field. The worms’ progression was 
recorded and a data set containing the number of worms responding (i.e. changing direction of 
forward movement) (Figure 12) to the switch in field direction was obtained.  
 
Worm Inlet + Electrode #1
Electrode #2
Microchannel
PDMS
Glass
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Figure 12: Time lapse of typical nematode behavior in electric field 
 
Figure 13 and Figure 14 plot the sensitivity of SENS and LEVR O. dentatum nematodes to electric 
field strength measured in straight microchannels. As shown in Figure 13, a low percentage (< 10%) 
of SENS and LEVR isolates respond to field strengths below 2V/cm. A higher percentage of worms 
start responding with increasing field strength; the percentage rise is sharper for LEVR isolate (45% 
increase for a 0.25V/cm change) compared to that for the SENS (25% increase for a 0.25V/cm 
change). The maximum percentage of worms responding to electric field saturates to 85% above 
2.5V/cm (n=202) for LEVR while it saturates to 80% above 4V/cm (n=100) for SENS.  
 
 
Figure 13: Electrotaxis sensitivity results (without drug) 
 
Using Graphpad’s prism software, the data was fitted with a Boltzmann sigmoid non-linear 
regression (Equation 3). From this model four important parameters can be quantified: (i) Top – the 
upper plateau of the plot, (ii) Bottom – the lower plateau of the plot, (iii) Slope – the steepness of 
the falloff between the top and bottom and (iv) VC50 – the electric field at which the number of 
worms responding is halfway between the top and bottom.  
 
(a)
t=6st=2s
t=16st=14st=12s
5V/cm
t=10s  
t=4s t=4st=0s
5V/cm E-Field Reversed
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Equation 3: Boltzmann sigmoid model 
 
Akaike’s information criteria (AIC) was then used to compare the differences [between SENS and 
LEVR] in these four parameters. Two global fit tests were conducted: the first compared the slope 
and VC50 of the two isolates’ response to determine if there is any phenotypic variation to report 
and the second compared the tops to determine if any variation in response needs to be accounted 
for in the later dose response experiments.  
 
  
Equation 4: Akaike's Information Criteria 
 
Akaike’s information criteria can summarize the fit of any non-linear model by the variable (ΔAIC) 
defined in Equation 4. In this equation, the sum of squares (SSi) is the sum of squared differences 
from the mean and represents the deviation for an entire sample set; and the degrees of freedom 
(DFi) is the number of values in the final calculation that are free to vary and represents a measure 
of model complexity. Thus, AIC gives a quantification of how the change in goodness-of-fit balances 
with the change in the number of degrees of freedom. If the net result is negative, then the change 
is SS is more than expected, so one concludes the more complicated (individual fit) is correct. If the 
net result is positive, the then simpler model (the global fit) is correct. From the ΔAIC variable, a 
‘correctness probability’ (Table 1) is generated to quantify the degree of likelihood a given model is 
correct.  
 
Table 1: Model comparisons for sensitivity (without drug) 
 
     Simpler model 2 parameters same
     Probability it is correct 5.77%
     Alternative model 2 parameters different
     Probability it is correct 94.23%
     Ratio of probabilities 16.34
     Preferred model 2 parameters different
AIC Comparison of Slope/VC50
     Simpler model Top same for all data sets
     Probability it is correct 92.96%
     Alternative model Top different for each data set
     Probability it is correct 7.04%
     Ratio of probabilities 13.21
     Preferred model Top same for all data sets
AIC Comparison of Tops
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As shown in Table 1 the AIC comparison of the slope and VC50 is indicative of a significant difference 
between the two isolates in the center region of the plot (2V ≤ x ≤ 3.5V). This gives strong evidence 
that a phenotypic variation between SENS and LEVR in the context of ability to sense an electric 
field. Although this variation is not completely in the scope of thesis, it is presented as an observation 
and it is expected other researchers may be able to advantageously use this difference. The more 
important AIC comparison of the tops reveals a 93% probability that there is no significant difference 
between the two isolates in the upper region of the plot (3.5V ≤ x). This result shows that in the later 
dose response experiments, an applied field ≈ 4.5 V/cm will induce an equivalent response in both 
SENS and LEVR.  
 
In another set of experiments, to ensure that electrotaxis could be used in combination with drug 
exposure, the O. dentatum nematodes were pre-treated with 3µM levamisole and their electrotaxis 
sensitivity was characterized. Figure 14 shows that 3µM levamisole does not significantly alter the 
electrotaxis sensitivity plots from Figure 13 – especially above 4.5V/cm (Fig. 3b,c).  
 
 
Figure 14: Electrotaxis sensitivity results (3 µM levamisole) 
 
Akaike’s information criteria was again used to ensure no statistical difference between the 
responses of drugged and un-drugged worms. Table 2 summarizes the AIC comparison of SENS 
drugged vs. un-drugged fits (left) and LEVR fits (right). 
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Table 2: Model comparisons for sensitivity (no drug vs. 3 µM Levamisole) 
 
 
As shown, AIC generates a ≥ 96.5% probability that there is no difference between the drugged and 
un-drugged fits for both SENS and LEVR. This illustrates that in both the presence and absence of 
Levamisole a field ≥ 4.5 V/cm can be used to reliably control the nematode population.   
Channel Resistance: Experimental and Results 
To find the maximum allowable current in the channel, the cathode voltage was fixed (between 4-
5V) and the electrical resistance of the device was varied (2MΩ to 11MΩ) by altering the ratio of 
agarose to water used to fill the microchannel. The direction of electric field was switched every 
minute and a data set of the number of worms paralyzed (i.e. immobilized) by the current was 
obtained (Figure 16).  
 
 
Figure 15: Comparison of low current (top) vs high current (bottom) nematode turn 
 
Figure 15 (top) shows the response of a representative LEVR nematode upon applying a 4.5V/cm 
electric field to a microchannel with an electrical resistance of ~12 MΩ (current in channel = 
~.37µA). Here the worm was initially travelling to the left side. Upon turning the field on, the worm 
     Simpler model 3 parameters same
     Probability it is correct 99.82%
     Alternative model 3 parameters different 
     Probability it is correct 0.18%
     Ratio of probabilities 554.17
     Preferred model 3 parameters same
     R square 0.9634
AIC Comparison of SENS Fits
     Simpler model 3 parameters same
     Probability it is correct 96.52%
     Alternative model 3 parameters different
     Probability it is correct 3.48%
     Ratio of probabilities 27.7
     Preferred model 3 parameters same
     R square 0.9669
AIC Comparison LEVR of Fits
4.5V/cm
E-Field ON Pullback Turnaround
t=0s t=4s t=12st=5s t=7s t=10s
4.5V/cm
E-Field ON Pullback Worm Paralysis
t=0s t=4s t=13st=5s t=7s t=9s
Rch = ~12 MΩ
Ich = ~.375 µA
Rch = ~2 MΩ
Ich = ~2.25 µA
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retracts or pulls back, turns its head around, and the rest of the body follows. Eventually, the worm 
moves to the right side in the direction of the applied field. Figure 15 (bottom) shows the response 
of a LEVR nematode upon applying a 4.5V/cm electric field to a microchannel with an electrical 
resistance of ~2 MΩ (current in channel = ~2.25 µA). Here the worm was initially travelling to the left 
side. Upon turning the field on, the worm retracts but quickly succumbs to the high current and 
paralyzes.   
 
Figure 16: Channel resistance results 
 
Again using the Boltzmann sigmoid non-linear regression (see Table 3 (left) for best fit values), 
Figure 16 plots the sensitivity of SENS and LEVR O. dentatum nematodes to the current flowing in 
the microchannel. The percentage of worms responding vs. channel resistance is shown. As the 
channel resistance was decreased, the current was increased and the natural movement of 
nematodes was hindered and eventually paralyzed. We measured the percentage of SENS and LEVR 
isolates being paralyzed at a certain channel resistance for a fixed voltage of 4-5V. Very few (< 5%; 
n= 30, SENS and n=36 , LEVR) SENS and LEVR nematodes paralyze at a channel resistance greater 
than 11MΩ, which corresponds to a channel current of less than 0.3µA. Above a channel a current 
of 1.5µA, most (>75%; n=28, SENS and n=58, LEVR) nematodes paralyze. 
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Table 3: Best fit and fit comparison for channel resistance 
      
 
An AIC comparison of the SENS and LEVR channel resistance fits (Table 3) shows an overwhelming 
probability that there is no difference between the isolates’ response to varying channel current. 
Again, this is important as it shows that no accommodations need to be made in the later dose 
response experiment for varying isolate response to the resistance of the channel. Thus, for later 
drug screening experiments, we chose a channel resistance of at least 10M to ensure that the 
worms’ natural movement was not hindered or paralyzed by the current.  
Response Time: Experimental and Results 
In an effort to fully characterize the electrotactic response of the nematodes, the response (aka 
sensing) time was characterized next. The response time is defined as the time from when the 
electric field is established to the time the nematode exhibits a characteristic response. It is noted 
here the response time was not crucial to the development of the dose assay, but is presented as an 
effort to convey all useful experimental data collected during this thesis research. 
The electrotaxis response time experiment was performed on our straight channel platform (Figure 
17). The worms and identical anodes were placed in all four I/O ports at the left end of the chip. 
Identical cathodes were place in all four I/O ports at the right end of the chip. The anodes were 
biased to 0V and the cathodes were biased to a negative voltage of choice [-2.5 V to -5 V].   
     Simpler model 2 parameters same for all data sets
     Probability it is correct >99.99%
     Alternative model 2 parameters different for each data set
     Probability it is correct <0.01%
     Ratio of probabilities
     Preferred model 2 parameters same for all data sets
     R square 0.9851
AIC Comparison of Fits
Best-fit values SENS LEVR
     Bottom 11.00% 20.00%
     Top 84.00% 92.00%
     V50 6Ω 6Ω
     Slope 1.142 0.5095
     R square 0.9999 0.9999
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Figure 17: Response time chip layout 
 
The worms’ movement was initially polarized to the right using a -5 V cathode bias. An LED was 
placed in parallel to channels such that it was reverse biased during the initial polarization. After a 
few seconds of polarized movement, the polarities of the systems were switched and, hence, the 
LED was forward biased. The entire progression was recorded at five frames per second and a data 
set containing the time from when the LED turned on until the time of the worms’ initial pull-back 
(Figure 15 (top)) was obtained (Figure 18).  
 
Figure 18: Response time results 
 
As shown in Figure 18, the response time for both isolates saturate to ~3-4 seconds near the right 
side of the plot (higher applied fields). Moving from right to left (higher to lower applied fields), the 
response time of both isolates begins to grow exponentially. An exponential change is intuitively 
expected as response times should grow quickly to infinity or some asymptote, at which there is no 
Distance Markers
Channels
Anode Ports
[off screen]
Cathode Ports
[off screen]
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response. From earlier experiments we know this asymptote should be located at ~2 V/cm. Thus, 
the data was fitted with an x=2 plateau-single phase decay model (Equation 5). 
 
 
Equation 5: Plateau-single phase decay model 
 
From this model, three important parameters can be quantified and compared: (i) Y0 – the 
estimated plateau at X0 = 2 V/cm, (ii) Plateau – the lower plateau at X≈5V/cm, and (iii) K – a 
measure of the quickness of decay between the two extremes. These best-fit values are summarized 
in Table 4 (left; SENS ≡ middle column; LEVR ≡ right column). 
 
Table 4: Best fit and fit comparison for response time 
 
 
Table 4 (right) shows an AIC comparison [between the SENS and LEVR fits] of the three parameters 
described above. As expected from Figure 18, there is a highly significant difference between the 
response times of the two isolates near the low end of the plot (x ≤ 3.5 V/cm). The information 
criteria shows a 99.95% probability that the aforementioned parameters are different for each data 
set. Although this data was in turn not used in the development of the RTHS dose assay, it is present 
as an observation noted during experimentation and we suspect this data could be advantageously 
used in other phenotypic screening devices.  
Effects on Motility 
To test whether motility parameters were affected by the electric field, we measured the average 
forward velocity of SENS and LEVR O. dentatum nematodes under different electric fields. As stated 
in Chapter I, the forward velocity of the nematode is closely related to the tangential force 
generated by the worm (Equation 1). As shown in Equation 1, the tangential force is proportional to 
Best-fit values SENS LEVR
     X0 2 V/cm 2 V/cm
     Y0 21.0 sec 9.0 sec
     Plateau 2.4 sec 3.7 sec
     K 1.2 3
     Half Life 0.6 0.2
     Tau 0.9 1/s 0.3 1/s
     Span 18.8 5.3
     Simpler model 3 parameters same for all sets
     Probability it is correct 0.05%
     Alternative model 3 parameters different for each set
     Probability it is correct 99.95%
     Ratio of probabilities 2211.87
     Preferred model 3 parameters different for each set
     R square 0.1882
AIC Comparison of Fits
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the wavelength and amplitude of the nematode (Figure 5). Thus, monitoring the forward velocity 
gives a reliable quantification as to the changing state of the nematodes’ motility. For electrotaxis to 
be a viable means of controlling the population’s movement, one would expect the average forward 
velocity should to unaffected by the applied field.  
 
 
Figure 19: Manual velocity measurement 
 
During this research, average forward velocity was measured by two means. First, velocity 
measurements were taken ‘by hand’. As depicted in Figure 19, the number of pixels per micrometer 
was first determined by measuring the pixel distance between two adjacent distance markers. An 
individual worm was then selected using the following criteria: (i) the worm’s forward movement 
should be unimpeded [by other worms or the channel boundaries] for at least 500 µm and (ii) the 
worm’s forward movement should be continuous and uninterrupted by a stop or turnaround. 
Second, in an effort to help correlate new tracking software developed by our research team, the 
velocity measurements were repeated using our automated measurement tool. Figure 20 shows a 
representative track output by our proprietary software. The track depicts the nematodes time 
lapsed x/y movement through the microchannel. The starting position, pull back point, turnaround 
spot, and ending position can all be readily identified.  
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Figure 20: Nematode path generated by tracking software 
 
As shown in Figure 20, two segments (forward and return trip between x=.05 mm and x=2.0 mm) of 
the track match the criteria for a reliable velocity calculation. Thus, a PERL script was written to 
recognize and extract these data points. From these data points, velocity was calculated and then 
compared to the manual measurement. It was found that the automated calculation correlated 
closely to the manual measurement.  
 
Figure 21 plots the average velocity for SENS and LEVR in both the presence (3 µM) and absence of 
Levamisole. The data was fit with an average value trend line; the mean and fit confidence values 
are shown in the figure.  
 
 
Figure 21: Electrotaxis velocity results 
 
X-Axis (mm)
Y-
A
xi
s 
(m
m
)
Pull Back
Turnaround
Start Position
End Position
Span of Velocity Measurement 
SENS SENS L LEVR LEVR L
     Mean 123 88 143 132
95% Confidence Intervals
     Mean
117 to 
130
82 to 
94.9
137 to 
150
122 to 
142
Goodness of Fit
     Sy.x 3.798 4.051 4.13 6.274
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As seen, the forward velocity is unchanged under various field strengths (143 ± 2.065 µm/s for LEVR 
and 123.4 ± 1.899 µm/s for SENS). When pre-treated with 3µM levamisole, the respective velocities 
decrease (131.8 ± 3.137 µm/s for LEVR and 88.43 ± 1.899 µm/s for SENS) due to the drug’s effects, 
but remain relatively unchanged under different electric fields. As shown by the confidence intervals 
and goodness of fit, the mean is contained within a small variance window. Thus, one can be 
confident in the abovementioned values. It should also be noted that the measured velocity data in 
the presence of an electric field closely correlates with our previous results on O. dentatum in 
straight microchannels (refer to Chapter I) and we can conclude motility is unaffected by the 
potential.  
Chemical Separation 
It was the primary aim of this research to realize a reliable, real-time drug screening platform 
independent of nematode species and to be adaptable to different test drugs. Having investigated 
an electrotactic method for guiding the nematodes through the microfluidic device, the challenge of 
administering an accurate dose of the test drug at real-time remained. Present day motility assays 
rely on a pre-treatment method in which nematodes are exposed to a dose for ~2 hours before 
being introduced into the assay. Hence, in order to accomplish real-time measurements of the drug 
effects, we developed a unique microfluidic-based method for filling the device and exposing the 
nematodes to the drug after they were introduced into the assay and under observation. 
 
Our initial attempts involved filling the entire microchannel and drug well with a 
drug/buffer/agarose mix. The worms were then placed in the I/O port and guided into the drug well. 
While accomplishing the real-time characterization goal, this limited our ability to quantify pre-
exposure locomotion parameters as the worms were exposed to the drug even in the 
microchannels. Our second attempt relied on a diffusion method in which we filled the 
microchannels and drug well with a buffer/agarose mix and then allowed the drug to diffuse into the 
drug well via the drug inlet. Although this method enabled real-time characterization and allowed us 
to monitor pre-exposure locomotion parameters, the rate of drug diffusion was difficult to control 
and, hence, the dose present in the drug well could not be accurately calibrated. In our successful 
attempt, we developed a method of filling the two sections (microchannels and drug well) of the 
device with two chemically-different (agarose/buffer and agarose/buffer/drug) media in a two-step 
process. To our knowledge, all prior microfluidic chips on C. elegans used a liquid medium (usually 
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M9 buffer) which made it difficult to chemically isolate two sections of a microfluidic device. 
Agarose provided a suitable medium in our devices to chemically separate the drug well from the 
microchannels.  
 
Figure 22: Chemical separation between channel and drug well 
 
All drug screening devices on a given fabricated chip (up to 16 devices/chip) were first filled with a 
octadecyltrichlorosilane (OTS) solution (OTS:n-hexadecane = 2:100 v/v) and left to dry at room 
temperature for ~2 hours. The OTS treatment coated the entire device with a thin film, changing the 
channel surfaces from hydrophilic to hydrophobic. The hydrophobic treatment provided better 
control of the flow profile. This allowed us to selectively fill the microchannels with an 
agarose/buffer mixture through the I/O port and then fill the drug well with agarose/buffer/drug 
mixture through the drug port. This two-step filling process enabled us to chemically separate the 
drug well from the microchannels and yet maintain the electrical conductivity throughout the 
device.    
Pilot Drug: Levamisole 
Levamisole was chosen as the pilot drug for our drug screening experiments as its dose response is 
well-characterized and it serves as a good standard to assess the performance of our microfluidic 
platform. From the experiments, we generated three dose response parameters: (i) percentage of 
worms responsive, (ii) percentage of worms leaving the drug well and (iii) average post-exposure 
velocity. As seen in the following subsections, each parameter inherently produces a different dose 
response and, hence, is a different measure of drug resistance. Compared to the measurement of a 
single dose response parameter (e.g. percentage of worms inhibited), the multiple parameters 
generated here provide redundancy from a single data set and enable a higher sensitivity when 
screening for drug resistance in a cross species, cross drug platform.  
 
After filling the microfluidic device (as described in the last section), nematode suspension was 
placed on the input port and worms were allowed to enter into the microchannels.  The anode, 
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biased at 0V, was placed in the I/O port and the cathode, biased at -5 V, was placed in the electrode 
port. A uniform electric field was established, thereby directing a finite number (~5 to ~15) of worms 
through the microchannel into the drug well. The worms’ progression was recorded and a data set 
of pre-exposure motility (i.e. velocity, wavelength, amplitude and track signature) was obtained. The 
electric field was kept for 15- 20 minutes which held the worms in the drug well and ensured they 
received maximum exposure to the drug. A data set of worm motility, including the number of 
worms paralyzed during the exposure time, was obtained. Subsequently, the direction of the electric 
field was reversed and the uninhibited (i.e. not paralyzed by the drug exposure) worms were guided 
from the drug well into the microchannels.  The worms’ progression was again recorded and a data 
set of post-exposure motility was obtained. A comparison between pre-exposed and post-exposed 
device parameters (average velocity of worms in microchannel, number of worms entering/leaving 
drug well, number of worms responsive in device) provided information about the dose response. 
Number of Worms Responsive: Parameter (i) 
Figure 23 (n=20-105) shows the percentage of responsive worms (parameter (i)) as a function of 
levamisole dose for O. dentatum. 
 
 
Figure 23: Number of worms responsive results 
 
Here we defined responsiveness as the ratio of the worms able to move outside a defined circular 
area of radius equal to its body length to the total worms in the device. Dose response parameter (i) 
closely resembles the inhibition parameter measured in traditional worm motility assays. 
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Equation 6: Three variable log(agonist) vs. response 
 
Using Graphpad’s prism software, the data was fitted using a three parameter dose response curve 
with a Hill slope of 1.0 (Equation 6). This standard model allowed us to determine the EC50 values, 
defined as the concentration that provokes a response half way between the basal and maximal 
response, of the agonist (levamisole). The following table (left) shows the best-fit values for SENS 
(middle column) and LEVR (right column) generated by this model.  
 
Table 5: Worms responsive best-fit values and fit comparison 
                                                                 
 
EC50 values of 13 µM (LogEC50 = 1.11 ± 0.11 µM) (SENS) and 32 µM (LogEC50 = 1.50 ± 0.07 µM) 
(LEVR) for O. dentatum were determined. For comparison, the EC50 values for levamisole on the 
survivability assay are 15 µM for SENS and 40 µM for LEVR.  
 
To compare the EC50 values of the two non-linear regressions shown in Figure 23, an extra sum-of-
squares F-test was performed. The test starts by assuming a ‘simpler model null hypothesis’. In this 
case, the global fit with Log(EC50) equivalent was chosen for the null hypothesis.  If this simpler 
model is actually correct, the relative increase in the sum of squares, when moving from the more 
complex to simpler model, is expected to equal the relative increase in degrees of freedom 
(Equation 7).  
 
     Null hypothesis LogEC50 same for all data sets
     Alternative hypothesis LogEC50 different for each data set
     P value 0.0271
     Conclusion Reject null hypothesis
     Preferred model LogEC50 different for each data set
     F (DFn, DFd) 11.62 (1,4)
F-Test Comparison of Fits
Best-fit values SENS LEVR
     Bottom 99.00% ~ 100.0%
     Top 0% 0%
     LogEC50 1.11 µM 1.50 µM
     EC50 13 µM 32 µM
     R square 0.9887 0.9941
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Equation 7: Null hypothesis rejection criteria for SOS F-test 
 
Where the sum of squares (SSi) is the sum of squared differences from the mean and represents the 
deviation for an entire sample set; and the degrees of freedom (DFi) is the number of values in the 
final calculation that are free to vary and represents a measure of model complexity. Using Equation 
7, an ‘F-ratio’, which quantifies the relationship between the relative increase in SS and DF, can be 
found (Equation 8).  
 
 
Equation 8: SOS F-test F-ratio 
 
From the F-value, one can confidently conclude which model is correct: (i) with an F-ratio ≈ 1 the 
simpler model is correct or (ii) with an F-ratio ˃ 1 the more complex model is correct. A P-value, 
which answers the question “if the simpler model is actually correct, what is the chance that you 
would randomly obtain data that fits the more complicated model better”, is then generated. Thus, 
with a high F-value (˃ 1) and a low P-value (< 0.05) one can reject the null hypothesis.  
 
The ratio of the EC50 values measured by parameter (i) (1.54) represented only a slightly significant 
(P-value = 0.0271 and F-value = 11.62) measure of drug resistance for the LEVR/SENS isolates. This 
highlights that in single parameter assays sensitivity is lost from species to species and drug to drug 
as the monitored parameter may not be the best measure of resistance for the species and drug 
under study. This issue is better addressed in our platform as the remaining two parameters show a 
higher resolution resistance measurement for the O. dentatum isolates. 
Number of Worms Leaving: Parameter (ii) 
Figure 24 shows the percentage of worms leaving the drug well (parameter (ii)) as a function of 
levamisole dose for C. elegans. 
 
𝑆𝑆1 − 𝑆𝑆2
𝑆𝑆2
≈
𝐷𝐹1 −𝐷𝐹2
𝐷𝐹2
 
𝐹 =
(𝑆𝑆1 − 𝑆𝑆2)/𝑆𝑆2
(𝐷𝐹1 − 𝐷𝐹2)/𝐷𝐹2
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Figure 24: Number of worms leaving results 
 
This data was fitted using the standard model described by Equation 6 (Hill Slope = 1). The best-fit 
values are summarized in the following table (left; SENS ≡ middle column; LEVR ≡ right column). 
 
Table 6: Worms leaving best-fit values and fit comparison 
  
 
As shown, parameter (ii) EC50 values of 2 µM (LogEC50 = 0.36 ± 0.07 µM) (SENS) and 12 µM 
(LogEC50 = 1.07 ± 0.09 µM) (LEVR) for O. dentatum. Again using the extra sum-of-squares F-test, the 
ratio of EC50 values measured by parameter (ii) (5.87) represented the most significant (P-value = 
0.0029; F-value = 41.82) measure of resistance for LEVR/SENS and further illustrates that a multiple 
parameter assay can have higher sensitivity than a single parameter assay.  
Average Worm Velocity: Parameter (iii) 
Figure 25 shows average worm velocity (parameter (iii)) as a function of levamisole dose for O. 
dentatum. Both pre- and post-exposure velocity are plotted to further highlight the effect of the 
drug. 
     Null hypothesis LogEC50 same for all data sets
     Alternative hypothesis LogEC50 different for each data set
     P value 0.0029
     Conclusion Reject null hypothesis
     Preferred model LogEC50 different for each data set
     F (DFn, DFd) 41.82 (1,4)
F-Test Comparison of Fits
Best-fit values SENS LEVR
     Bottom 92.00% 93.00%
     Top 0% 0%
     LogEC50 0.36 µM 1.07 µM
     EC50 2 µM 12 µM
     R square 0.9968 0.9921
34 
 
 
 
Figure 25: Average worm velocity results 
 
This data was fitted using the standard model described by Equation 6 (Hill Slope = 1). The best-fit 
values are summarized in the following table (left; SENS ≡ middle column; LEVR ≡ right column). 
 
Table 7: Average worm velocity best-fit values and fit comparison 
 
 
As shown, parameter (iii) produced EC50 values of 2 µM (LogEC50 = 0.38 ± 0.16 µM) (SENS) and 12 
(LogEC50 = 1.09 ± 0.08 µM) (LEVR) for O. dentatum. Again using the extra sum-of-squares F-test, the 
ratio of EC50 values measured by parameter (iii) (5.43) reaffirmed the significance (P-value = 0.0155; 
F-value = 24.86) of the resistance measure from parameter (ii) for LEVR/SENS. This again shows the 
advantage of the redundancy in a multi-parameter platform presented in this research over current 
single-parameter assays.  
Average Exposure Time: Parameter (iv) 
     Null hypothesis LogEC50 same for all data sets
     Alternative hypothesis LogEC50 different for each data set
     P value 0.0155
     Conclusion Reject null hypothesis
     Preferred model LogEC50 different for each data set
     F (DFn, DFd) 24.86 (1,3)
F-Test Comparison of Fits
Best-fit values SENS LEVR
     Bottom 114 µm/s 128 µm/s
     Top 0% 0%
     LogEC50 0.38 µM 1.09 µM
     EC50 2 µM 12 µM
     R square 0.9853 0.9946
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Figure 26 plots the time response of the drug effect on the nematodes for a therapeutic dose of 100 
µM levamisole. The sample minimum, lower quartile, median, upper quartile and sample maximum 
of the total time from exposure to paralysis for O. dentatum are displayed. 
 
Figure 26: Box and whisker of paralysis time 
 
The drug effect is established (i.e. full paralysis of the test nematode) in SENS (median = 2.05 
minutes; n=17) quicker than in LEVR (6.74 = minutes; n=14. This shows, our drug screening device 
offers a unique advantage of monitoring the real-time effects of drug exposure with the ability to 
characterize the locomotion parameters at a single worm resolution.  
 
 
Figure 27: Time lapse of typical time to paralysis for 100 µM Levamisole 
 
Figure 27 shows time lapsed images of a single SENS nematode being exposed to a 100 µM dose of 
levamisole in the drug well. For the initial 2 minutes, there were no observable changes in the 
worm’s sinusoidal movement. Within the next 2 minutes, we observed that the worm gradually 
curled up and is eventually paralyzed. Further, the drug effect time response can be used as fourth 
parameter of resistance. With a two-tailed, nonparametric hypothesis test a comparison of the 
LEVR/SENS medians revealed a difference of 4.68 minutes and a P-value of 0.0016. This represents a 
significant difference between the isolates and gives further knowledge as to the level of resistance 
t=0s t=30s t=60s t=120s
t=150s t=180s t=210s t=240s
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in the LEVR isolate and the associated changed phenotype. Further details on this hypothesis test 
are shown below. 
 
 
Equation 9: Mann-Whitney non-parametric hypothesis test 
 
In the Mann-Whitney non-parametric hypothesis test, the entire data set is ranked from low to high. 
No concern is given to which subset (i.e. SENS or LEVR data) a given sample comes from and each 
data point is assigned a ranking number. The ranks are then summed according to which subset they 
belong to; that is, the ranks for all SENS samples are summed as well as the ranks for all LEVR points. 
Since the total population studied here is rather large (>10-15) a Gaussian approximation to the 
distribution of ranks is assumed. It should be noted that the data sets themselves were not assumed 
to be Gaussian, but only their rankings. Using Equation 9, the Mann-Whitney U is calculated and 
compared to the Mann-Whitney Umedian. From this statistical comparison, a P-value is generated and 
one can answer the question “If the population really have the same median, what is the chance 
that random sampling would result in medians as far apart (or more so) as observed in this 
experiment”. Thus, with a P-value <.05 one can confidently conclude that the medians of the two 
data sets compared are significantly different. Table 8 summarizes the Mann-Whitney test results 
for the O. dentatum exposure time data.  
 
Table 8: Comparison of exposure time medians 
 
RTHS Dose Assay: An Outlook 
P value 0.0016
Exact or approximate P value? Gaussian Approximation
Are medians signif. different? Yes
One- or two-tailed P value? Two-tailed
Sum of ranks in column C,D 192 , 304
Mann-Whitney U 39
Mann Whitney test
37 
 
Good engineering not only entails a thorough solution to the task at hand, but also offers some 
outlook as to how the current solution could be improved upon. Figure 28 shows a 3-D rendering of 
a next generation RTHS dose assay.  
 
Figure 28: 3-D model of next generation RTHS dose assay chip 
 
In order to simplify the assembly and create a more consistent experiment, the platinum electrodes 
have been moved on board as indium-doped tin oxide (ITO) patterned onto the glass slide. To keep 
the cost per chip low, the ITO coated glass would become a permanent fixture; consecutive 
sonications in an ethanol:methanol mixture and de-ionized water would be used to keep the glass 
clean. The upper PDMS chip would remain disposable and could be fabricated with different channel 
widths, thicknesses and slight variations in design for specific applications. The channel design has 
been slightly modified to allow for easier filling of the drug wells and for the ability to record 6-8 
wells simultaneously. The assembly is held together and temporarily sealed by the outer black 
frame. This allows for a single ITO slide to be used with numerous interchangeable PDMS chips.  
 
The above chip should be used in combination with other ‘off-chip’ improvements to further 
streamline the system.  A programmable syringe pump should be configured to fill a precise volume 
of channel and drug well agar. This would null the need for OTS treatment, create a more repeatable 
experiment, and further ‘dummy-proof’ the assay. Improvements to the tracking software would 
create a more consistent analysis and would further automate the testing procedure. Real-time 
tracking and worm counting software should be implemented to display average velocity and worm 
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counts at real-time. Volume of movement software should be implemented in order to track worm 
paralysis and instantaneously display exposure times.     
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Chapter IV: Electrotactic Nematode (EN) Gate 
As the electrotactic behavior of the nematodes was being studied in chapter III a small but 
potentially useful idea to use electrotaxis in a gating application was generating. Although this 
project is unrelated to the dose assay, it is a byproduct of the research used to develop the bioassay 
and is expected to make an impact in the C. elegans community. Thus, the research, results and 
discussions uses to develop this idea are presented in the subsequent chapter.  
Background: Problem Statement 
Microfluidic valves have become a cornerstone feature in popular fluidic devices. These valves are 
typically used to control the flow of fluid through the device, or, in some cases, a combination of the 
movement of flow and particles. Monolithic, pneumatic valves are of the most common structures 
in this class. They comprise two sets of PDMS microchannels bonded perpendicular to each other 
and separated by a thin PDMS membrane. Pressure applied through the top channel (e.g. via air or 
fluid flow) collapses the PDMS membrane and controls the flow in the bottom channel. Other 
examples include the mechanical pinch valve, in which a screw or ball bearing type structure is 
imbedded into the PDMS just above the microchannel. To close the valve, the experimentalist drives 
the screw or bearing downward to effectively pinch-off the flow in the channel. Although effective, 
these valves are generally large static structures, lack the potential for automation and, in some 
cases, require a multistep molding process. Further, these valves are typically tailored to control the 
flow in the channel and, thus, scope is left to tool a new generation of valves specifically for in vivo 
testing, especially for free moving (i.e. no moving fluid) nematode bioassays.   
EN Gate Proposal 
Figure 29 models the proposed electrotactic gate. For testing purposes, numerous gating options 
were integrated onto a straight-channel microfluidic device. The actual gate comprises only two 
main components (an anode channel/port and a cathode channel/port) and can be incorporated 
into any microfluidic design.  The electrode ports (xx µm radius) are connected to the microfluidic 
device via a thin channel that is 10 µm in width and 50 µm in length. These parameters are relatively 
arbitrary and can be adapted to any system with the only design constraint being that electrical 
conductivity must be kept between the two electrodes.  
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Figure 29: Electrotactic gate chip layout with virtual gate shown (red) 
 
In the depicted scheme, electrode #1 is biased at 0V and electrode #2 at -10V, establishing an 
electric field directed towards electrode #1. The field, confined to the lateral channel region 
between the two electrodes, produces a virtual valve (shown in red) near the cathode.  As 
predicated from the electrotaxis experiments discussed in chapter III, a worm incident from the 
electrode #1 side will sense a field in the same direction as its forward movement and pass through 
the valve uninhibited. A worm incident from the electrode #2 side, however, will sense a field in the 
opposite direction of its movement and will turn around at the valve interface. Switching the 
polarities of the two electrodes (i.e. electrode #1=-10V and electrode #2=0V) will effectively change 
the direction of allowed movement through the virtual valve, and moving the electrodes to different 
ports on the chip will effectively shift the position of the valve. Thus, the electric field acts as 
dynamic gate that can be rotated, shifted and even fully removed. Further, because the gate is 
electrically activated, a simple program can be used to control the gate’s state and the assembly can 
be fully incorporated into an automated lab-on-chip assay.    
EN Gate Results and Discussions 
Figure 30 (single worm) and Figure 31 (multiple worms) show the typical response of an N2 C. 
elegans nematode incident on the electrotactic gate.  The nematode approaches from the right, 
subsequently penetrating a certain depth into the electric field before pulling back and turning 
around. As depicted, this ‘penetration depth’ shifts the effective gate a small distance from the end 
of the field lines (i.e. from electrode #2).  
 
Worm Inlet
Electrode #2
Electrode #1
Virtual Valve
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Figure 30: Typical nematode response at the electrotactic gate 
 
 
 
Figure 31: Multiple worms held by the electrotactic gate 
 
 
Figure 32 shows the performance of the electrotactic gate for the wild-type N2 C. elegans and the 
acr-16 and lev-8 mutants.  As plotted, >95% of the wild-type N2 (n=21; N=3) and acr-16 (n=21; N=3) 
mutant were held by the gate, while 100% (n=21; N=3) of the lev-8 mutant were turned back. This 
produces as overall effectiveness of ~97%. The 3% loss (i.e. 2 of 63 worms) was due to experimental 
conditions and it is suspected that a completely polished system will generate a 100% effectiveness 
(i.e. all worms held by the gate).  
 
t=0s
t=6s t=8s
t=2s
t=10s
t=4s
Effective gate
End of field 
Penetration
Depth
t=0s
t=6s t=8s
t=2s
t=10s
t=4s
Worm #1 Stopped Worm #2 Stopped Worm #3 Stopped
Worm #4 Stopped
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Figure 32: Electrotactic gate performance 
 
We have defined the penetration depth depicted in Figure 30 as the distance from the end of the 
electric field lines to the furthest point within the field reached by an incident nematode. Figure 33 
plots the penetration depth of the C. elegans studied. The sample minimum, lower quartile, median, 
upper quartile and sample maximum are shown.  
                                  
Figure 33: Electrotactic gate penetration depth 
 
Figure 33 shows medians ranging from 20 µm (lev-8; n=21) to 233 µm (N2; n=21) with the acr-16 
median between at 76 µm (n=21).  Further experimentation shows that electrodes separated by 
distances grossly under these medians dramatically reduces the performance of the proposed 
device. Thus, design considerations should be made for the nematode species under test.  
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Conclusions 
In conclusion, a new bioassay for screening anthelmintic drugs on both C. elegans and parasitic 
nematodes was presented. The system offers reduced experimental time, higher sensitivity, and, for 
the first time, real-time observation of drug effects at a single worm resolution. It was shown that 
the dose response measured from three device parameters (i.e. average velocity, number of worms 
leaving the drug well, and the number of active worms) have a better sensitivity (i.e. lower EC50, 
lower P values, and higher F values) than the survivability tests in motility assays. Further, the three 
device parameters offer redundancy from a single data set, which was not possible with previous 
motility assays. This demonstration of a faster, more accurate real-time microfluidic drug screening 
device is expected to help future work on new and existing anthelmintics, their rapid screening, and 
elucidation of underlying cellular/molecular interactions with the nematode. More generally, the 
capability of real-time control and visualization of phenotypic changes in a microorganism is useful 
for future lab-on-chip behavioral assays where environmental (such as chemical, physical, 
neurophysiological, and/or social) adaptability can be studied.         
 
In a second project, a microfluidic method for gating nematodes at a micro-scale resolution was 
presented. The proposed electrotactic nematode gate was shown to be effective for >95% of 
incident worms and offers the advantages of reduced size, easier fabrication, and automation 
capabilities over current fluidic valves. It is expected the presented device will help to streamline 
new and existing bioassays, especially in the C. elegans community.    
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